198 related articles for article (PubMed ID: 16769552)
1. Adjuvant treatment strategies for pancreatic cancer.
Newman EA; Simeone DM; Mulholland MW
J Gastrointest Surg; 2006 Jun; 10(6):916-26. PubMed ID: 16769552
[TBL] [Abstract][Full Text] [Related]
2. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
[TBL] [Abstract][Full Text] [Related]
3. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
Lluís F
Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
[No Abstract] [Full Text] [Related]
5. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
[TBL] [Abstract][Full Text] [Related]
6. The treatment of pancreatic cancer.
Yeo CJ; Cameron JL
Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
[No Abstract] [Full Text] [Related]
7. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer.
Vento P; Mustonen H; Joensuu T; Kärkkäinen P; Kivilaakso E; Kiviluoto T
World J Gastroenterol; 2007 Jun; 13(21):2945-51. PubMed ID: 17589944
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
Breslin TM; Hess KR; Harbison DB; Jean ME; Cleary KR; Dackiw AP; Wolff RA; Abbruzzese JL; Janjan NA; Crane CH; Vauthey JN; Lee JE; Pisters PW; Evans DB
Ann Surg Oncol; 2001 Mar; 8(2):123-32. PubMed ID: 11258776
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant and neoadjuvant therapy in curable pancreatic cancer.
Nugent FW; Stuart K
Surg Clin North Am; 2010 Apr; 90(2):323-39. PubMed ID: 20362789
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial.
Heinrich S; Schäfer M; Weber A; Hany TF; Bhure U; Pestalozzi BC; Clavien PA
Ann Surg; 2008 Dec; 248(6):1014-22. PubMed ID: 19092346
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of pancreatic cancer.
Collins A; Bloomston M
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):445-54. PubMed ID: 19942828
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
Abbruzzese JL
JAMA; 2008 Mar; 299(9):1066-7. PubMed ID: 18319419
[No Abstract] [Full Text] [Related]
15. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).
Maurel J; Sánchez-Cabús S; Laquente B; Gaba L; Visa L; Fabregat J; Povés I; Roselló S; Díaz-Beveridge R; Martín-Richard M; Rodriguez J; Sabater L; Conill C; Cambray M; Reig A; Ayuso JR; Valls C; Ferrández A; Bombí JA; Ginés A; García-Albéniz X; Fernández-Cruz L
Cancer Chemother Pharmacol; 2018 Dec; 82(6):935-943. PubMed ID: 30225601
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Shivnani AT
JAMA; 2007 Jun; 297(23):2581-2; author reply 2582. PubMed ID: 17579222
[No Abstract] [Full Text] [Related]
18. Neoadjuvant strategies for pancreatic cancer.
Evans DB; Wolff RA; Crane CH
Oncology (Williston Park); 2001 Jun; 15(6):727-37; discussion 741-4, 747. PubMed ID: 11430206
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer.
Li D; O'Reilly EM
Surg Oncol Clin N Am; 2016 Apr; 25(2):311-26. PubMed ID: 27013366
[TBL] [Abstract][Full Text] [Related]
20. Curative radiation therapy for pancreatic malignancies.
Cooke EW; Hazard L
Surg Clin North Am; 2010 Apr; 90(2):341-54. PubMed ID: 20362790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]